PHARMACEUTICAL SOLUTIONS LIMITED
Company number 03749261 · Active
PHARMACEUTICAL SOLUTIONS LIMITED is a private limited company registered in CHESTER, United Kingdom, incorporated on 8 Apr 1999. Its registered activity is other professional, scientific and technical activities n.e.c.. Its latest published accounts for the period ending 31 Mar 2025 show equity of £939k, total assets of £1.1m. It has filed 5 sets of accounts. Our model estimates a 0.03 % probability that it becomes insolvent within 12 months, 0.2 times the average for active companies (low risk).
Insolvency risk, next 12 months
Higher than 89 % of active companies in the United Kingdom. 0.2× the average annual insolvency rate (0.12 %).
Raises the risk
Lowers the risk
Each factor compares companies in the same group (for example the same age band) with the average. The score is a statistical estimate from public data (model AUC 0.99, trained 8 Nov 2026), not a credit rating. How it works.
Company details
- Company number
- 03749261 · official register
- Status
- Active
- Legal form
- Private Limited Company
- Incorporated
- 8 Apr 1999 (28 years)
- Registered address
- CH3 5NE CHESTER
- Postcode area
- Chester
- Activity
- 74909 Other professional, scientific and technical activities n.e.c.
- Industry
- Other professional, scientific and technical activities
- Accounts overdue
- No
Insolvency and register events
No insolvency or liquidation events on record.
Annual accounts GBP
| Period end | Published | Turnover | Result | Equity | Total assets | Current liabilities | Cash | Employees |
|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 15 Dec 2025 | – | – | £939k | £1.1m | £143k | £754k | 7 |
| 31 Mar 2024 | 15 Dec 2024 | – | – | £890k | £1.1m | £183k | £747k | 6 |
| 31 Mar 2022 | 15 Dec 2022 | – | – | £766k | £894k | £128k | £540k | 5 |
| 31 Mar 2021 | 15 Dec 2021 | – | – | £618k | £667k | £50k | £500k | 5 |
| 31 Mar 2020 | 15 Dec 2020 | – | – | £695k | £835k | £140k | £230k | 6 |
As published. Small companies often file a balance sheet only, so turnover and result can be missing.
Similar companies in Chester
- 1337 SOLUTIONS LIMITED WIRRAL
- 365 DESIGN AND ADVERTISING LIMITED HESWALL
- 39 WESTBOURNE ROAD MANAGEMENT COMPANY LIMITED WIRRAL
- 3D GROUND SCANNING SURVEYS LTD CHESTER
- 4 BERESFORD ROAD MANAGEMENT COMPANY LIMITED BIRKENHEAD
- 44, SEABANK ROAD, WALLASEY MANAGEMENT COMPANY LIMITED WALLASEY
- 460 MEDIA LTD WALLASEY
- 4TH FLOOR DESIGN LTD MOLD
- 4W ENVIRONMENTAL LIMITED CHESTER
- 7 PLY STUDIO LIMITED WIRRAL
- 777 MARKETING LTD CHESTER
- 8ENJAMIN LAMPREY LIMITED WIRRAL
Questions about PHARMACEUTICAL SOLUTIONS LIMITED
What is the company number of PHARMACEUTICAL SOLUTIONS LIMITED?
PHARMACEUTICAL SOLUTIONS LIMITED is registered under company number 03749261 in the official register of United Kingdom. View it at the official register.
Is PHARMACEUTICAL SOLUTIONS LIMITED still active?
Yes. PHARMACEUTICAL SOLUTIONS LIMITED is registered as active (status: Active).
Has PHARMACEUTICAL SOLUTIONS LIMITED gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for PHARMACEUTICAL SOLUTIONS LIMITED in the official data.
How likely is PHARMACEUTICAL SOLUTIONS LIMITED to become insolvent?
Our model estimates a 0.03 % probability that PHARMACEUTICAL SOLUTIONS LIMITED becomes insolvent within the next 12 months (low risk). That is higher than 89 % of active companies in the United Kingdom.
When was PHARMACEUTICAL SOLUTIONS LIMITED founded?
PHARMACEUTICAL SOLUTIONS LIMITED was incorporated on 8 Apr 1999.
Where is PHARMACEUTICAL SOLUTIONS LIMITED registered?
PHARMACEUTICAL SOLUTIONS LIMITED's registered address is in CH3 5NE CHESTER (Chester), United Kingdom.
What do the latest accounts of PHARMACEUTICAL SOLUTIONS LIMITED show?
The latest published accounts (period ending 31 Mar 2025) show equity of £939k, total assets of £1.1m, 7 employees.
Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 8 Nov 2026.